FOI 2025/1236

**A word document was sent to the requester with this response.  If you require a copy of the full response, together with the attachments, please contact NHS GM’s FOI team – nhsgm.foi@nhs.net.**

2.     GM Shared Care Forerunner Scheme

**A word document was sent to the requester with this response.  If you require a copy of the full response, together with the attachments, please contact NHS GM’s FOI team – nhsgm.foi@nhs.net.**

2.     Shared Care of Medicines – GM scheme as above

3.     Locally commissioned Bolton Quality contract

**A word document was sent to the requester with this response.  If you require a copy of the full response, together with the attachments, please contact NHS GM’s FOI team – nhsgm.foi@nhs.net.**

**A word document was sent to the requester with this response.  If you require a copy of the full response, together with the attachments, please contact NHS GM’s FOI team – nhsgm.foi@nhs.net.**

(note that this includes GM Antimicrobial Stewardship specification)

a.     Antimicrobial Stewardship (Meet prescribing targets for total, broad-spectrum  and duration of some ABs;  (Refer to GM AMS scheme for details) 

b.     Medicines Safety: SMASH Dashboard targets

c.     Prescribing Spend Targets

d.     Shared Care of Medicines (Refer to GM Scheme for details).

2.     Shared Care of Medicines –  GM scheme as above

2.     Shared Care of Medicines –  GM scheme as above

2.     Shared Care of Medicines –  GM scheme as above

2.     Prescribing of addictive medications:

Each practice to prepare a plan outlining their approach to reducing addictive medications for 2025/26. Plan to be submitted by 1^st July 2026.

Achieve a reduction in number of patients or dose for patients on 120mg Oral Morphine Equivalent (OME) – excludes patients with cancer

3.     Antimicrobial Stewardship (GM standardised specification)

4.     Optimise patients with known CVD and Diabetes (high risk group) (GM standardised specification)

5.     Shared Care – Shared Care requirements including those within GM Shared Care Forerunner to include

a)    Undertake required searches and maintain a shared care register

b)    Coding to the required standards as highlighted in the specification

c)     Short survey in Q1&Q4 completed

d)    Nominate a clinician to join an engagement session in Q3

e)    Undertake QI audit for declined requests

a.     Reduction in COST per APU through Patient-Led Ordering, Increase repeat prescriptions through NHS App

b.    Review patients identified as overordering their medication by reducing the number of over-threshold patients

c.     Reduce the mean carbon emissions per Salbutamol inhaler prescribed (kg CO2e)

2.     Medicines Safety

a.     Reduce the risk of harm for patients prescribed ≥120mg Morphine (or equivalent), excluding cancer-related pain and palliative care

b.    Nominate a representative to join the upcoming Tameside Pain Collaborative Group

c.     Reduce the PCN total indicator population of patients identified as potentially at risk from their prescribed medications on the SMASH Dashboard

3.     Antimicrobial Stewardship – GM AMS Scheme – Details above

4.     Value for Money

a.     Reduce weighted prescribing of Drugs of Limited Clinical Value as advised by NHS England not to be routinely prescribed in primary care

b.    Reduce weighted prescribing of “Do Not Prescribe” medications as advised by GMMMG

c.     Reduce prescribing of High-Cost Drugs.

5.     Shared Care

a.     Provider shall provide a drug initiation or continuation and monitoring service, in accordance with the Greater Manchester Medicines Management Group (GMMMG) approved Shared Care Protocols (SCP).

b.     A Shared Care Protocol should be signed and uploaded to the Patients Medical Record as confirmation to the shared care responsibilities.  Practices should maintain records in line with the Shared Care Protocol. Activity is required to be coded

·       Engagement with NHS GM – Tameside Medicines Optimisation Team

·       Communication and Information Sharing

·       Quarterly Reporting and Follow-Up Meetings

·       Bi-Monthly PCN/MO Team Meetings

·       Adherence to GMMMG Recommendations

2.     Shared Care of Medicines –  GM scheme as above

2.     Shared Care of Medicines –  GM scheme as above

2.      Shared Care Shared Care – Shared Care requirements including those within GM Shared Care forerunner scheme to include:

·       Undertake required searches and maintain a shared care register

·       Coding to the required standards as highlighted in the specification

·       Short survey in Q1&Q4 completed

·       Nominate a clinician to join an engagement session in Q3

·       Undertake QI audit for declined requests

Shared care: £1.40 php

Frailty: £1.30php

The funding for Medicines Optimisation bundle within the Locally Commissioned Service is set at £1.70 per head of population, allocated as above

Shared Care: For majority of patients where the GP takes responsibility after specialist initiates quarterly payments of £14.30 will be paid from when the patient is stable for as long as the patient continues to be supported through the shared care protocol.

Specifically, for some Rheumatology patients where the GP may choose to accept responsibility to initiate in line with Model b) Primary care prescribes and monitors from the beginning with support/ guidance from secondary care. Payment for initiation is £28.62 for the first quarter, thereafter quarterly payments of £14.30 will then be paid if the patient continues to be supported through the shared care protocol.